Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
EWTX compared with PRLD: revenue, margins and what each company keeps, and the suppliers and customers both name
EWTX
Edgewise Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
PRLD
Prelude Therapeutics Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
EWTX
Edgewise Therapeutics, Inc.
vs
PRLD
Prelude Therapeutics Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
EWTX, solid
PRLD, dashed
Supply-chain overlap
Revenue flow
EWTX: latest quarter not drawable. PRLD: latest quarter is a loss; flow not drawable.
Method
›
EWTX
Edgewise Therapeutics, Inc.
Change
38.93
· pre 39.06
· delayed
Mkt cap
$4.2B
Revenue
—
PRLD
Prelude Therapeutics Inc
Change
3.89
· pre 3.89
· delayed
Pre-market
Oct 30 '26
delayed
Mkt cap
$309.6M
Revenue
$6M
Q2 FY26
vs
Compare
Pre-market
Oct 30 '26
delayed
EWTX
Edgewise Therapeutics, Inc.
vs
PRLD
Prelude Therapeutics Inc
38.93
pre 39.06
delayed
Price
3.89
pre 3.89
delayed
$4.2B
Mkt cap
$309.6M
—
Revenue
$6M
Q2 FY26
Change
Change
EWTX
38.93
vs
PRLD
3.89
Pre-market
Oct 30 '26
delayed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only EWTX
2
—
Leerink
unlisted
supplier
—
Silicon Valley Bank (SVB)
unlisted
supplier
Shared
0
No shared counterparties.
Only PRLD
3
INCY
Incyte
customer
ABCL
AbCellera Biologics
customer
—
Pathos AI
unlisted
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR